Table 2.

Higher risk of systemic lupus erythematosus in anti-Toxoplasma gondii antibodies immunoglobulin G population

ATxA-IgG type	Healthy controls (N, %)	SLE patients (N, %)	Odds ratio (95% CI)	Odds ratio (95% CI) (age/sex adjusted)	P-valuea
ATxA-IgG−	855 (94.2)	719 (83.3)	Reference	Reference
ATxA IgG+	53 (5.8)	144 (16.7)	3.23 (2.32–4.49)	2.48 (1.70–3.62)	< 0.0001*

ATxA IgG⁺, Anti-Toxoplasma gondii antibodies immunoglobulin G-positive, ATxA IgG⁻ anti-Toxoplasma gondii antibodies immunoglobulin G-negative, CI confidence interval

*Statistically significant

^aP value for the comparison with matched healthy controls